a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with MDXG. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then MDXG could also see price increases.
Ticker / NAME | Correlation To VCEL | 1D Price Change % | ||
---|---|---|---|---|
VCEL | 100% | -5.05% | ||
MDXG - VCEL | 49% Loosely correlated | -6.73% | ||
FOLD - VCEL | 48% Loosely correlated | +0.17% | ||
NTLA - VCEL | 44% Loosely correlated | -3.65% | ||
CPRX - VCEL | 43% Loosely correlated | -2.52% | ||
BEAM - VCEL | 43% Loosely correlated | -8.55% | ||
More |
Ticker / NAME | Correlation To VCEL | 1D Price Change % |
---|---|---|
VCEL | 100% | -5.05% |
stem cells theme (21 stocks) | 53% Loosely correlated | +0.41% |
treatment theme (61 stocks) | 51% Loosely correlated | +0.91% |
medical research theme (128 stocks) | 50% Loosely correlated | +0.46% |
medical service theme (156 stocks) | 48% Loosely correlated | +0.31% |
cellular theme (5 stocks) | 24% Poorly correlated | -0.79% |